A detailed history of Paradigm Biocapital Advisors LP transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Paradigm Biocapital Advisors LP holds 4,539,381 shares of KURA stock, worth $76.9 Million. This represents 3.78% of its overall portfolio holdings.

Number of Shares
4,539,381
Previous 3,135,387 44.78%
Holding current value
$76.9 Million
Previous $66.9 Million 39.76%
% of portfolio
3.78%
Previous 2.51%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$17.53 - $22.98 $24.6 Million - $32.3 Million
1,403,994 Added 44.78%
4,539,381 $93.5 Million
Q1 2024

May 15, 2024

BUY
$13.42 - $23.53 $25.1 Million - $44.1 Million
1,872,559 Added 148.28%
3,135,387 $66.9 Million
Q4 2023

Feb 14, 2024

BUY
$7.58 - $14.38 $379,000 - $719,000
50,000 Added 4.12%
1,262,828 $18.2 Million
Q3 2023

Nov 14, 2023

BUY
$8.44 - $11.86 $1.75 Million - $2.47 Million
207,920 Added 20.69%
1,212,828 $11.1 Million
Q2 2023

Aug 14, 2023

BUY
$9.62 - $13.99 $9.67 Million - $14.1 Million
1,004,908 New
1,004,908 $10.6 Million

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $1.13B
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Paradigm Biocapital Advisors LP Portfolio

Follow Paradigm Biocapital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Biocapital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Biocapital Advisors LP with notifications on news.